CONMED (NASDAQ:CNMD) Director
Stephen Mandia sold 3,899 shares of CONMED stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $49.97, for a total value of $194,833.03. Following the completion of the transaction, the director now directly owns 18,501 shares in the company, valued at approximately $924,494.97. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
CNMD has been the subject of a number of recent research reports. Analysts at Ladenburg Thalmann downgraded shares of CONMED from a “buy” rating to a “neutral” rating and set a $55.00 price target on the stock in a research note on Friday, April 24th. Analysts at Piper Jaffray reiterated a “neutral” rating and set a $51.00 price target (up previously from $47.00) on shares of CONMED in a research note on Thursday, April 23rd. Analysts at Needham & Company LLC raised their price target on shares of CONMED from $54.00 to $56.00 and gave the company a “buy” rating in a research note on Thursday, April 23rd. Finally, analysts at Zacks reiterated a “sell” rating and set a $45.00 price target on shares of CONMED in a research note on Friday, March 27th. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $53.83.
